ORIENT BIO Inc. (002630.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 3Aug 6Aug 11Aug 14Aug 20Aug 25Aug 28Sep 2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−13.8x

Market Cap

KRW 108.26B

MomentumView details →

1D Return

+8.69%

YTD Return

−24.04%

RSI (14)

47.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−13.8x

Market Cap

KRW 108.26B

RSI (14)

47.2

MomentumView details →

1D Return

+8.69%

YTD Return

−24.04%

ProfitabilityView details →

Gross Margin

17.46%

Net Margin

−27.80%

EBITDA Margin

−19.19%

ROE (TTM)

−12.12%

ROA (TTM)

−10.22%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+1.75%

EPS YoY

—

FCF YoY

+92.36%

Revenue CAGR 3Y

+3.81%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

11.45x

Quick Ratio

10.80x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

29.54B

Net Income (TTM)

−8.21B

Op. CF (TTM)

1.36B

Latest newsMore news →

No recent news for 002630.KS.

Similar companies

Vaxcell-Bio Therapeutics Co., Ltd.323990.KQ Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK Sino Biopharmaceutical Limited01177.HK iNtRON Biotechnology, Inc.048530.KQ MedPacto, Inc.235980.KQ Innovent Biologics, Inc.01801.HK Find similar companies →

Latest newsMore news →

No recent news for 002630.KS.